Medical/Pharmaceuticals
Malaysia Healthcare Week Debuts in Kuwait, Strengthening Malaysia-Kuwait Medical Partnership
Spearheaded by the Malaysia Healthcare Travel Council, the event builds momentum towards the Malaysia Year of Medical Tourism 2026. KUWAIT CITY, Kuwait, Sept. 17, 2025 /PRNewswire/ -- Building on Malaysia's established reputation as a premier global healthcare destination and as part of the stra...
2025-09-17 10:01
2752
Genesis MedTech J-VALVE® TF Approved by NMPA, China's First Transfemoral TAVR for Aortic Regurgitation
Clinical data demonstrate low mortality, fewer complications and faster patient recovery with a minimally invasive alternative to open-heart surgery SINGAPORE, Sept. 17, 2025 /PRNewswire/ -- Genesis MedTech's structural heart subsidiary, Suzhou Jiecheng, has received approval fromChina's National...
2025-09-17 07:30
2248
EADV Congress 2025: Atopic eczema linked to significantly higher risk of suicidal thoughts
PARIS, Sept. 17, 2025 /PRNewswire/ -- A new international study presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that adults with atopic eczema (AE) are significantly more likely to experience suicidal thoughts. As one of the largest global inve...
2025-09-17 06:01
1558
New Scientific Review Highlights β-Lactoglobulin's Dual Benefits for Metabolic and Muscle Health
Emerging evidence positions this dairy protein as a powerful nutritional ingredient – and 21st.BIO's precision fermentation could make it more sustainable than ever. COPENHAGEN, Denmark, Sept. 16, 2025 /PRNewswire/ -- β-Lactoglobulin (BLG), the most abundant whey protein in cow's milk is drawing...
2025-09-16 21:47
1571
Over 100 Healthcare Professionals Convene to Explore the Critical Impact of Early Nutrition on Long-Term Brain Development
Mead Johnson Clinical Study Reveals the Sustained Cognitive Benefits of Milk
Fat Globule Membrane (MFGM)
Photo download: Link
2025-09-16 19:41
2070
ShiraTronics Announces Positive 12-Month Follow-Up Results from RELIEV-CM Pilot Study, Demonstrating Sustained Clinical Benefit with Investigational Implantable Neuromodulation Therapy for Chronic Migraine
MINNEAPOLIS, Sept. 16, 2025 /PRNewswire/ -- ShiraTronics, Inc., a clinical-stage medical device company focused on developing novel neuromodulation therapies for chronic migraine, today announced compelling 12-month follow-up data from its RELIEV-CM Pilot Study. The findings demonstrate sustaine...
2025-09-16 19:00
1372
ALCOR Scientific Transforms ESR Testing: Extends Blood Sample Stability from 4 to 28 Hours
Diagnostic Company's iSED Analyzers Deliver Seven-Fold Stability Increase to Improve Accuracy, Efficiency, and Patient Care SMITHFIELD, R.I., Sept. 16, 2025 /PRNewswire/ -- ALCOR Scientific today announced a breakthrough in erythrocyte sedimentation rate (ESR) testing that solves one of the most...
2025-09-16 19:00
1450
LA MER DOUBLES DOWN ON MIRACLE BROTH™ WITH NEW BIOENERGETICS RESEARCH PLATFORM AND LANDMARK PARTNERSHIP WITH THE SALK INSTITUTE
THE PLATFORM LAUNCHES WITH 'LA MER GIVES SKIN LIFE' CAMPAIGN & A THREE-YEAR HEALTHY AGING FELLOWSHIP HONG KONG, Sept. 16, 2025 /PRNewswire/ -- La Mer has long been known to provide skin with cellular energy and has remained dedicated to exploring the bioenergetic efficacy of Miracle Broth, from ...
2025-09-16 13:50
1444
Celebrating Cross-Border Partnerships in Healthcare, Asia Medical Week 2025 Convened Leaders in Bali to Strengthen Excellence and Preparedness
BALI, Indonesia, Sept. 16, 2025 /PRNewswire/ -- The Asia Medical Week (AMW) and the Asia Medical Innovation and Development Forum 2025 officially took place fromSeptember 12-13 in Bali with a mission to bring together healthcare leaders from acrossAsia to strengthen cross-border collaboration and...
2025-09-16 13:37
1615
Globally Significant Opportunity Emerges as Remplir™ is used in Nerve-Sparing Prostate Cancer Surgery
Potential to reduce the risk of erectile dysfunction and urinary incontinence PERTH, Australia, Sept. 16, 2025 /PRNewswire/ -- Regenerative medicine company Orthocell Limited (ASX:OCC, "Orthocell" or the "Company") is pleased to announce its flagship nerve repair device, Remplir, has been introdu...
2025-09-16 12:13
1693
Chulalongkorn Bariatric and Metabolic Institute (Chula BMI), a One-Stop Service Center for Holistic Obesity Treatment
BANGKOK, Sept. 16, 2025 /PRNewswire/ -- Say goodbye to obesity with the
Chulalongkorn Bariatric and Metabolic Institute (Chula BMI)
2025-09-16 10:00
2197
Baxter Launches HEMOPATCH Sealing Hemostat in New Zealand, a Room-Temperature Collagen Pad Approved for Hemostasis and Sealing
DEERFIELD, Ill., Sept. 15, 2025 /PRNewswire/ -- Over the past two decades, surgical techniques have increasingly shifted toward minimally invasive approaches, requiring adapted workflows and skillsets. At the same time, patient complexity has grown, calling for tailored strategies to support safe...
2025-09-16 06:00
1641
LabConnect and OmniScience to Deliver First Agentic AI Solution for Real-Time Clinical Trial Lab Insights
Together we're unlocking the true potential of clinical trial lab data, bringing faster insights, smarter decisions, and better outcomes. JOHNSON CITY, Tenn. and HOUSTON, Sept. 15, 2025 /PRNewswire/ -- LabConnect, a leading global provider of central laboratory services today announced plans to ...
2025-09-15 21:03
1518
SI GROUP TO SHOWCASE SUSTAINABLE ADDITIVE INNOVATIONS AT K 2025
Industry Leader Presents Advanced Solutions for Plastics and Rubber THE WOODLANDS, Texas, Sept. 15, 2025 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals, and chemical intermediates, will showcase its portfolio of ...
2025-09-15 20:30
1517
FutureCeuticals Files Lawsuit Against NeuroRush Owner for Patent Infringement over Alleged Copycat Ingredient
MOMENCE, Ill., Sept. 15, 2025 /PRNewswire/ -- VDF FutureCeuticals, Inc. filed a lawsuit against Aura Scientific, asserting that its brain performance ingredient NeuroRush – an extract of whole coffee fruit – infringes multiple of FutureCeuticals' patents covering technology relating to coffee fru...
2025-09-15 20:00
2464
Rona Therapeutics Announces IND Filing of RN3161, a Highly Potent and Durable INHBE siRNA for Obesity
SHANGHAI and SANTA BARBARA, Calif., Sept. 15, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, announced today the successful submission of RN3161 to the Australian Human Research Ethics Committee (HREC).RN3161 is a proprietary GalNAc-conjug...
2025-09-15 20:00
1832
Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer Inc
Australian scientists who discovered how to "turn off" genes that make cancer cells grow are celebrating the next phase of development – with Pfizer's first in class KAT6 inhibitor PF-07248144 now moving to the next stages of clinical investigation. MELBOURNE, Australia, Sept. 15, 2025 /PRNewswi...
2025-09-15 12:06
1390
New Data, iCARE Study: Hailie® Smartinhaler® Powers Unprecedented Medication Adherence in Patients with COPD and Asthma
Highlights: * Up to 235% increase in real-world adherence compared to published norms (20–40%), across ~850 chronic obstructive pulmonary disease (COPD) and asthma patients. * >60% patients achieved an average two-week baseline adherence with ~4 in 10 patients reaching the critical threshold...
2025-09-15 12:05
1775
MGI Tech Introduces DNBSEQ-T7+: A Next-Generation 'Data Mining Machine' for Genomics
SHENZHEN, China, Sept. 15, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, announced the launch of the DNBSEQ-T7+, its latest high-throughput sequencer. Designed to meet the rising demand for larg...
2025-09-15 11:53
1733
Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations
SINGAPORE and GUANGZHOU, China, Sept. 15, 2025 /PRNewswire/ -- Lion TCR, a clinical-stage biotechnology company pioneering T-cell receptor (TCR)-based therapies, today announced that it has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to initi...
2025-09-15 08:00
1566
Week's Top Stories
Most Reposted
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 278 media titles]
2025-12-26 12:55ACEN completes transition to 100% renewable energy
[Picked up by 273 media titles]
2025-12-29 18:53Vietnam's Newest EDM Destination, APLUS SAIGON, Debuts With Star-Studded Soft Opening Weekends Featuring Dombresky and Argy
[Picked up by 273 media titles]
2025-12-30 20:12
iQIYI LAND Yangzhou to Open on February 8, Marking New Chapter in China's Immersive Entertainment Scene
[Picked up by 271 media titles]
2026-01-01 10:00
CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 263 media titles]
2025-12-29 09:00
